Literature DB >> 6175321

Abnormalities in the content of nucleic acids of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

D Alarcón-Segovia, L Llorente, E Fishbein, E Díaz-Jouanen.   

Abstract

We have completed 59 cytofluorographic studies of DNA/RNA content in acridine orange-stained peripheral blood mononuclear cells from 44 patients with systemic lupus erythematosus, most of whom received no medications. Most such cells were in resting phases of the cell cycle, particularly those from patients with inactive disease. Nine patients with systemic lupus erythematosus had increased percentages of these cells in the synthesis and postsynthesis phases of the cell cycle; the B lymphocyte had a greatest proportions of activated cells. In 11 patients, we found that cells, particularly T lymphocytes, had increased RNA content without a proportional increase in DNA. This DNA block occurred primarily in patients with serum antibodies to DNA and it could be reproduced in normal mitogen-stimulated mononuclear cells incubated in heat-inactivated sera from patients with systemic lupus erythematosus whose own cells showed abnormalities of DNA/RNA content or in purified native DNA antibody. The DNA blocking potential of the DNA antibody was dependent on its Fc portion and on the presence of Fc receptors on T cells. Thus, saturation of Fc receptors by pretreatment with aggregated IgG or incubation with the whole antibody in the cold prevented the DNA block, indicating that it was an active process.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6175321     DOI: 10.1002/art.1780250308

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  4 in total

1.  Increased DNA and/or RNA content of synovial fluid cells in rheumatoid arthritis: a flow-cytometry study.

Authors:  B Bonvoisin; G Cordier; J P Revillard; E Lejeune; M Bouvier
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

Review 2.  Antinuclear antibody profiles in relation to specific disease manifestations of systemic lupus erythematosus.

Authors:  A J Swaak; V Huysen; J C Nossent; R J Smeenk
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

3.  Stimulating and differentiation factors for human B lymphocytes in systemic lupus erythematosus.

Authors:  E Martinez-Cordero; J Alcocer-Varela; D Alarcon-Segovia
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

4.  Differential abnormality in cell-cycle stage of peripheral B cells from patients with systemic lupus erythematosus.

Authors:  M Hara; A Kitani; M Harigai; T Hirose; K Norioka; W Hirose; K Suzuki; M Kawagoe; H Nakamura
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.